# Trade Mark Journal No.2026/005 30 January 2026

## WO0000001896360 (1,5,42)

Office of origin: United States of America

Date of International Registration:1 December 2025
Date of designation in the UK: 1 December 2025

International priority date claimed: 25 November 2025 (United States of America) (99516659)
International priority date claimed: 25 November 2025 (United States of America) (99516662)
International priority date claimed: 25 November 2025 (United States of America) (99516665)

Class 1
  Assays for scientific and research use.
Class 5
  Medical diagnostic assays for detecting, measuring, and analyzing proteins, protein fragments, plasma cells, and antibodies for medical purposes; diagnostic biomarker reagents for medical purposes.
Class 42
  Design and development of biochemical assays.

PROTEGO BIOPHARMA, INC.

Representative: Brian J. Focarino Cooley LLP, 1299 Pennsylvania Ave. NW STE 700, Washington DC 20004, UNITED STATES OF AMERICA